![Seul-Ki Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 175 M $ al 30/09/2026
Dr. Seul-Ki Lee is a Chief Executive Officer & Director at Neuraly, Inc. and a CEO, Director, Head-Research & Technology at D&D Pharmatech Co., Ltd. He is on the Board of Directors at Neuraly, Inc. and D&D Pharmatech Co., Ltd. Dr. Lee was previously employed as a Chief Executive Officer by Theraly Fibrosis, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
D&D PHARMATECH CO., LTD. 12,34 % | 30/06/2026 | 5.655.524 ( 12,34 % ) | 175 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| D&D PHARMATECH INC. | Director Ejecutivo | - |
Neuraly, Inc.
 Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Fundador | 01/01/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Director Ejecutivo | 01/01/2024 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Neuraly, Inc.
Neuraly, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in physical and biological research | Commercial Services |
Theraly Fibrosis, Inc.
Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
D&D Pharma Tech Co., Ltd.
 D&D Pharma Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
